Neuralert addresses the problem of late or undetected stroke in hospitalized patients.
Penn and Carisma Therapeutics (Carisma) have strengthened the intellectual property portfolio covering this technology with the issuance of five additional patents in 2022.
Launched in 2021, Vivodyne’s platform allows fully automated, complex studies at a far larger scale and lower cost than would be possible with manual experimentation.
Dr. Johnson and a team of collaborators have launched Recupero Robotics with the help of PCI Ventures.
Their innovative work was recognized by the Philadelphia Business Journal's PHL Inno initiative, which awards people 25 years and younger who are making an impact in the area’s startup ecosystem.
PCI Startup SchoolSims Named One of the 100 Fastest Growing Companies in the Philadelphia Region by Philadelphia100® Forum
SchoolSims is an education company that offers technology-enhanced immersive learning solutions to leadership development for educational and other organizations.
Penn Health-Tech is well known for turning innovative ideas across the health system into useful technologies and products that solve problems and advance health care.
Penn Spinout Verismo Therapeutics Announces Submission of Investigational New Drug Application to the FDA for KIR-CAR T-cell Immunotherapy Candidate
Pending regulatory approval, Verismo plans to use the drug in patients with mesothelin-expressing ovarian cancer, mesothelioma and cholangiocarcinoma.
PCI Startup Vital Start Health Wins 2022 Citizens Small Business Community Champions Award for their Work in Neonatal Care
PCI startup Vital Start Health empowers clinicians and caregivers by giving them a digital platform to improve neonatal care.
Exelon Corporation and the non-profit Exelon Foundation are searching for promising early-stage companies to invest in for the 4th annual Climate Change Investment Initiative (2c2i).